Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Stomach Neoplasms 1Skin Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cyclophosphamide 17fludarabine phosphate 12Rituximab 12Peripheral Blood Stem Cell Transplantation 12Filgrastim 11Cyclosporine 11Whole-Body Irradiation 8Mycophenolic Acid 8Radiotherapy 7Busulfan 7Antilymphocyte Serum 7Vincristine 6Prednisone 6Melphalan 6Etoposide 6Methotrexate 5Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Therapeutics 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Doxorubicin 3Cytarabine 3Carmustine 3Aprepitant 3Analgesia 3plerixafor 2Vindesine 2Tacrolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Large B-Cell, Diffuse × Clarithromycin × Clear all
NCT00201422 2016-03-28

Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

National Health Research Institutes, Taiwan

Phase NA Completed
70 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡